![Page 1: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/1.jpg)
IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH
IN FOSTER CARE
Oregon CHCS team Advisory Committee
June 15, 2013
![Page 2: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/2.jpg)
PROPOSED STRATEGIES AND NEXT STEPS
►INFORMATION►CONSENT►CLINICAL PRACTICE
![Page 3: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/3.jpg)
Information
►Youth in foster care (YOUTH ADVOCACY GROUPS) What to expect in foster care and rights
►Need a pamphlet to adopt ►Need a method to distribute and help
comprehend with a supportive adult (or peer for older youth).
Review of Psychiatric Medications►Alternatives to guide to healthy choices pamphlet►Need a method to distribute and help
comprehend with a supportive adult (or peer for older youth).
![Page 4: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/4.jpg)
Information
►Foster Parents: Trauma training
►Involve the AMH trauma sub committee ►Involve PSU training
Establish a curriculum Establish a method of consistent training
CPS training►Work with OHSU CPS advisory committee to
develop curriculum and strategy for implementation
Medication / health care training►In place, need to improve process and materials
![Page 5: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/5.jpg)
Information
►DHS Staff Trauma training
►Involve the AMH trauma sub committee ►Involve PSU training
Establish a curriculum Establish a method of consistent training
CPS training►Work with OHSU CPS advisory committee to
develop curriculum and strategy for implementation
Medication / health care training►In place, need to improve process and materials►Implement consultation and second opinion
strategies.
![Page 6: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/6.jpg)
Information
►Providers:►Dashboards►Trauma informed clinics and clinicians
AMH trauma sub committee
►Evidence Based Guidelines OPAL K guidelines reviewed by OCCAP Process for provider buy-in Data can help providers manage their programs
![Page 7: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/7.jpg)
Consent ► Current:
Clinician PARC (informs) with child and possibly the caregiver
Clinician fax form 173C to DHS Caregiver notifies caseworker of prescription Caseworker reviews information with supervisor to
authorize beginning of medication► Proposed new process
Clinician PARC (informs) with child and caregiver Caregiver provides information to
caseworker/supervisor (verbal and written 173C) Supervisor and caseworker reviews information
(department protocols) Caseworker notifies caregiver when and if to proceed
with medication regime
Subject to Legal review
![Page 8: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/8.jpg)
Clinical Practice
►Disseminate Prescribing Flags Poly pharmacy greater than 4 Medication without an assessment Medication without a diagnosis Medication for children under six Antipsychotics
►Under six►Multiple►Longer than 6 months without a diagnosis
![Page 9: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/9.jpg)
Clinical Practice
►Oversight Initiate a process for oversight of requests
for new antipsychotic for any child and any psychotropic for a child under the age of 6►Initiate a process for providing and receiving
feedback Dashboards to providers Dashboards to CCOs TED When flags triggered
►Communicate with provider►Peer review through DHS MD or via OPAL K
![Page 10: IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013](https://reader036.vdocuments.mx/reader036/viewer/2022072013/56649e715503460f94b705e8/html5/thumbnails/10.jpg)
Next Steps
►Training and education workgroup Treatment of Aggression workgroup
►Legal and practical review of consent process►Trauma training: coordination with CSAC
Trauma Committee initiatives. PSU foster parent training program
►Building CPS capacity to serve Foster families►Building connections with CCOs►What happens if OPAL K is a no go?